Paradigm Medical Industries, Inc. (PDMI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2011 | -474 Thousand USD | 51.03% |
| 2010 | -968 Thousand USD | -1.89% |
| 2009 | -950 Thousand USD | 45.05% |
| 2008 | -1.72 Million USD | 0.12% |
| 2007 | -1.73 Million USD | 4.68% |
| 2006 | -1.81 Million USD | 66.3% |
| 2005 | -5.38 Million USD | -8520.31% |
| 2004 | 64 Thousand USD | 102.02% |
| 2003 | -3.16 Million USD | 71.66% |
| 2002 | -11.15 Million USD | -9.98% |
| 2001 | -10.14 Million USD | -9.01% |
| 2000 | -9.3 Million USD | -158.47% |
| 1999 | -3.6 Million USD | -28.57% |
| 1998 | -2.8 Million USD | 0.0% |
| 1997 | -2.8 Million USD | -100.0% |
| 1996 | -1.4 Million USD | -75.0% |
| 1995 | -800 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2011 FY | -474 Thousand USD | 51.03% |
| 2010 FY | -968 Thousand USD | -1.89% |
| 2009 Q1 | -282 Thousand USD | 23.99% |
| 2009 FY | -950 Thousand USD | 45.05% |
| 2008 FY | -1.72 Million USD | 0.12% |
| 2008 Q1 | -566 Thousand USD | -323.72% |
| 2008 Q4 | -371 Thousand USD | -40.0% |
| 2008 Q3 | -265 Thousand USD | 51.64% |
| 2008 Q2 | -548 Thousand USD | 3.18% |
| 2007 FY | -1.73 Million USD | 4.68% |
| 2007 Q4 | 253 Thousand USD | 208.12% |
| 2007 Q2 | -1.5 Million USD | -505.65% |
| 2007 Q1 | -248 Thousand USD | -2580.0% |
| 2007 Q3 | -234 Thousand USD | 84.42% |
| 2006 Q4 | 10 Thousand USD | 103.17% |
| 2006 Q2 | -755 Thousand USD | 0.13% |
| 2006 FY | -1.81 Million USD | 66.3% |
| 2006 Q1 | -756 Thousand USD | 46.87% |
| 2006 Q3 | -315 Thousand USD | 58.28% |
| 2005 Q4 | -1.42 Million USD | -293.09% |
| 2005 FY | -5.38 Million USD | -8520.31% |
| 2005 Q2 | -3.27 Million USD | -914.24% |
| 2005 Q3 | -362 Thousand USD | 88.95% |
| 2005 Q1 | -323 Thousand USD | -160.48% |
| 2004 FY | 64 Thousand USD | 102.02% |
| 2004 Q4 | -124 Thousand USD | -125.78% |
| 2004 Q3 | 481 Thousand USD | 587.14% |
| 2004 Q2 | 70 Thousand USD | 119.23% |
| 2004 Q1 | -364 Thousand USD | 57.48% |
| 2003 Q1 | -703 Thousand USD | 81.62% |
| 2003 FY | -3.16 Million USD | 71.66% |
| 2003 Q4 | -856 Thousand USD | -2413.51% |
| 2003 Q3 | 37 Thousand USD | 102.26% |
| 2003 Q2 | -1.64 Million USD | -133.29% |
| 2002 Q2 | -1.87 Million USD | 9.74% |
| 2002 Q3 | -3.38 Million USD | -81.03% |
| 2002 FY | -11.15 Million USD | -9.98% |
| 2002 Q4 | -3.82 Million USD | -12.9% |
| 2002 Q1 | -2.07 Million USD | 31.81% |
| 2001 Q4 | -3.04 Million USD | -19.08% |
| 2001 FY | -10.14 Million USD | -9.01% |
| 2001 Q3 | -2.55 Million USD | 4.35% |
| 2001 Q2 | -2.66 Million USD | -41.74% |
| 2001 Q1 | -1.88 Million USD | 49.22% |
| 2000 Q4 | -3.7 Million USD | -110.32% |
| 2000 FY | -9.3 Million USD | -158.47% |
| 2000 Q1 | -1.37 Million USD | 14.13% |
| 2000 Q2 | -2.08 Million USD | -51.89% |
| 2000 Q3 | -1.76 Million USD | 15.52% |
| 1999 Q1 | -700 Thousand USD | 50.0% |
| 1999 Q4 | -1.6 Million USD | -23.08% |
| 1999 Q2 | - USD | 100.0% |
| 1999 FY | -3.6 Million USD | -28.57% |
| 1999 Q3 | -1.3 Million USD | 0.0% |
| 1998 FY | -2.8 Million USD | 0.0% |
| 1998 Q4 | -1.4 Million USD | -133.33% |
| 1998 Q3 | -600 Thousand USD | -100.0% |
| 1998 Q2 | -300 Thousand USD | 25.0% |
| 1998 Q1 | -400 Thousand USD | 42.86% |
| 1997 Q1 | -100 Thousand USD | 85.71% |
| 1997 Q4 | -700 Thousand USD | 0.0% |
| 1997 Q3 | -700 Thousand USD | 12.5% |
| 1997 FY | -2.8 Million USD | -100.0% |
| 1997 Q2 | -800 Thousand USD | -700.0% |
| 1996 Q3 | -600 Thousand USD | -500.0% |
| 1996 Q1 | -300 Thousand USD | 0.0% |
| 1996 FY | -1.4 Million USD | -75.0% |
| 1996 Q2 | -100 Thousand USD | 66.67% |
| 1996 Q4 | -700 Thousand USD | -16.67% |
| 1995 Q4 | -300 Thousand USD | -50.0% |
| 1995 Q1 | -200 Thousand USD | 0.0% |
| 1995 FY | -800 Thousand USD | 0.0% |
| 1995 Q2 | -200 Thousand USD | 0.0% |
| 1995 Q3 | -200 Thousand USD | 0.0% |
| 1994 Q4 | -200 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 48.861% |
| Ansell Limited | 76.5 Million USD | 100.62% |
| Ansell Limited | 76.5 Million USD | 100.62% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 24.28 Million USD | 101.952% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 70.925% |
| Psykey, Inc. | -1.32 Million USD | 64.198% |
| ConvaTec Group Plc | 130.3 Million USD | 100.364% |
| ConvaTec Group Plc | 130.3 Million USD | 100.364% |
| Encision Inc. | -691.78 Thousand USD | 31.481% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -234.248% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | -102.248% |
| Innovative MedTech Inc. | -7.93 Million USD | 94.029% |
| LifePoint, Inc. | -15.23 Million USD | 96.888% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 93.041% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | -72.712% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | -3.262% |
| SmileDirectClub, Inc. | -86.4 Million USD | 99.451% |
| Sector 10, Inc. | 7036.00 USD | 6836.782% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 100.024% |
| SheerVision, Inc. | -71.37 Thousand USD | -564.089% |
| United Health Products, Inc. | -2.62 Million USD | 81.931% |
| Vasamed, Inc. | -4.88 Million USD | 90.303% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 80.155% |
| Yubo International Biotech Limited | -1.2 Million USD | 60.656% |